Home Mycophenolic acid Print Save Mycophenolic acidGeneric name: mycophenolic acid [ MYE-koe-phe-NOLE-ik-AS-id ] Brand name: Myfortic Dosage form: oral delayed release tablet (180 mg; 360 mg) Drug class: Selective immunosuppressantsMedically reviewed by Drugs.com on Jan 19, 2024. Written by...
Only mycophenolic acid (MPA), an active metabolite of MMF, efficiently inhibited osteosarcoma cell growth with IC50 values of 0.46-7.3 渭M; these values are in the therapeutic range for organ transplant patients. At a therapeutic dose (10 渭M), MPA significantly inhibited colony formation, ...
1) 货号: 03121475; 2) 中文品名: 霉酚酸-D -葡萄糖醛酸苷标准品; 3) 英文品名: Mycophenolic acid -D-glucuronide; 4) CAS No. 31528-44-6; 5) 分子式、分子量; C23H28O12;496.46 g.mol-1; 6)同位素含量: N/A; 7) 规格: 10 mg, 100 mg, 1 g; 8) 备注: 药物及代谢物标准品 甄准免费...
麦考酚酸肠溶片药品报告提供了麦考酚酸肠溶片的各种信息,包括麦考酚酸肠溶片的药品简介,新药研发进度,仿制药申报进度,中国药品注册情况,一致性评价进度,药品临床试验进度,药品上市等信息.更多药物报告的查询就在戊戌数据药物报告数据库.
Mycophenolic acid, less accurately called mycophenolate, is a compound derived from Penicillium stoloniferum and related species. It can reversibly inhibit inosine monophosphate dehydrogenase (IMPDH), the enzyme that controls the rate of synthesis of gua
1 药品名称 MYCOPHENOLIC ACID 申请号 091248 产品号 001 活性成分 MYCOPHENOLIC ACID 市场状态 处方药 剂型或给药途径 TABLET, DELAYED RELEASE;ORAL 规格 360MG 治疗等效代码 AB 参比药物 否 批准日期 2014/01/08 申请机构 MYLAN PHARMACEUTICALS INC 2 药品名称 MYCOPHENOLIC ACID 申请号 091248 产品号 002 活性...
(acmpag), with the parent drug. with the use of the acquity uplc i-class plus separation coupled with the xevo tqd for mass detection, this challenge can be faced with ease. the chromatographic resolution of the acquity uplc i-class plus of the metabolites mycophenolic acid glucoronide (...
Therapeutic drug monitoring of mycophenolic acid in patients with psoriasis Volume 20, numéro 3, May-June 2010 PDF Imprimer Ajouter à mes favoris Citer cet article Envoyer un lien vers article Partager sur Facebook Partager sur Twitter Partager sur Google+ Partager sur LinkedIn Résumé ...
The present invention provides antibodies useful in assays for mycophenolic acid (MPA). These antibodies bind MPA and are able to distinguish MPA from its esters, such as morpholinoethyl E-6-(1,3-dihy
Whereas therapeutic drug monitoring (TDM) is well established for other immunosuppressants, the use of this tool for individualization and optimization of mycophenolate therapy remains a matter of debate during these years. This article focuses on the basic pharmacology of mycophenolic acid and current ...